Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chongqing Xishan Science and Technology Co (SHSE:688576) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Chongqing Xishan Science and Technology Co ROCE % Related Terms
Chongqing Xishan Science and Technology Co ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co ROCE % Chart
Chongqing Xishan Science and Technology Co Annual Data
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a ROCE % of 1.24% as of Mar. 2026.
Is Chongqing Xishan Science and Technology Co's ROCE % too high?
Chongqing Xishan Science and Technology Co's current ROCE % is 1.24%. The Medical Devices & Instruments industry median ROCE % is 2.30. Chongqing Xishan Science and Technology Co's value of 1.24% is 46% below this industry median. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's ROCE % compare to ISRG and BDX?
Chongqing Xishan Science and Technology Co's ROCE % of 1.24% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. Chongqing Xishan Science and Technology Co's value of 1.24% is 46% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current ROCE % of 1.24% is 46% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current ROCE % is 1.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥53.66, compared to a current price of ¥36.33 — trading 32.3% below its estimated fair value. The current ROCE % is 1.24% and 46% below the Medical Devices & Instruments industry median of 2.30. Chongqing Xishan Science and Technology Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current ROCE % is 1.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥36.33 is trading 32.3% below its estimated GF Value™ of ¥53.66.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688576:
ROCE %: 1.24%
GF Value™: ¥53.66 vs. price of ¥36.33 (32.3% below fair value)
Industry Position: 46% below the Medical Devices & Instruments median
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Xishan Science and Technology Co Business Description
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
85GF Score
Get the complete analysis for SHSE:688576
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
